Market Research Report

Global Gene Panel Market Research Report: Forecast (2024-2030)

Global Gene Panel Market Report - By Product & Service (Test Kits, Testing Services), By Technique (Amplicon Based Approach, Hybridization Based Approach), By Design (Predesigned G...ene Panel, Customized Gene Panel), By Application (Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others), By End User (Academic & Research Institutes, Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies), and Others Read more

  • Healthcare
  • Oct 2024
  • 176
  • PDF, Excel, PPT

Market Definition

A gene panel is a set of multiple genes defined to analyze the mutations or variations associated with a specific disease or condition. This type of testing can help determine an individual's risk for developing certain conditions and follow the most effective treatment decisions as soon as possible.

Market Insights and Analysis: Global Gene Panel Market (2024-30):

The Global Gene Panel Market size was valued at around USD 3.1 billion in 2023 & is estimated to grow at a CAGR of around 14.2% during the forecast period, i.e., 2024-30. This market is expected to see significant revenue growth driven by an increase in cases of cancer and genetic diseases. Gene panels that test for various gene variations at once for a specific disease are becoming essential for precise medicines. The increase in the number of cancer cases which show 20 million cases diagnosed globally in 2022, depicts the emerging need for Gene Panels for targeted and personalized treatment.

Report Coverage Details
  Historical Years   2019-22
  Base Years
  2023
  Forecast Years
  2024-30
  Market Value in 2023   USD 3.1 Billion
  CAGR (2024-30)   14.2%
  Leading Region   North America
  Top Key Players Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen Inc., Eurofins Scientific Se, BGI, F. Hoffmann-La Roche AG, Integrated DNA Technologies Inc., Genewiz, Inc., Novogene Corporation, Personalis, Inc., Gatc Biotech AG, Archerdx, Genedx, Centogene AG, and others
  Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation,
  • Recent Strategic Moves by Companies,
  • Primary Stakeholders,
  • Analysis of Import and Export Trends,
  • Competitive Landscape Assessment,
  • Emerging Opportunities,
  • Market Trends and Indicators

 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Additionally, the growing demand for personalized medicine presents a good opportunity for the gene panel industry. Personalized treatment plans rely on identifying specific genetic mutations, in which gene panel plays a critical role. Advancements in next-generation sequencing (NGS) have made these tests much more affordable and accessible, even for lower-income countries.

Moreover, technological advancements such as the integration of gene panels with artificial intelligence and the collaboration of gene panel developing companies with institutions and pharmaceuticals for innovation keep giving the market a forward push. These innovations are helping the industry to get more accurate and efficient results and fulfill the need for highly precise diagnostic tools worldwide. Thus, such technological advancements are changing market dynamics and offering lucrative growth potential for the leading market players.

However, the market has to face some challenges like the lack of skilled workforce and lack of health awareness in various regions. Either a skilled workforce or automated systems are required to get the full benefit of the available healthcare assets worldwide. Thus, effective handling of these challenges would augment the size & volume of the Gene Panel Industry during the forecast period.


Global Gene Panel Market Research Report: Forecast (2024-2030)

Global Gene Panel Market Driver:

Increasing incidences of Cancer & Genetic Disorders – The increase in the number of cancer and other genetic disorders are the key drivers of the Gene Panel Market. For instance,

  • As per Global Cancer Statistics 2024, an estimated 20 million cancer cases were newly diagnosed in 2022 and 9.7 million people died from the disease worldwide. By 2050, the number of cancer cases is predicted to reach around 35 million.

An increase in such cases drives the demand for genetic tests that can identify specific mutations and guide some targeted treatment or therapy. Additionally, an increase in awareness against genetic disorders fuels the need for gene panels for early diagnosis and management if found some symptoms. Multi-genes panels focus on a wide range of genetic conditions simultaneously hence finding the disorder in no time. Moreover, as gene panels diagnose only a specific set of genes instead of all genes inside the body, they save time as well as cost hence increasing their demand and ultimately augmenting the revenue growth of the gene panel industry globally.

Global Gene Panel Market Opportunity:

Increasing Demand for Personalized Medicines – A personalized treatment for a specific disorder emerges as an outstanding opportunity for the market players. As the healthcare industry is increasingly shifting towards personalized treatment plans, the need for gene panels that can identify specific genetic disorders is continuously increasing. Such a panel will enable the healthcare industry to provide required treatment and therapies to the patients as per their genetic profiles, improving the efficiency of treatment as well as the time of cure. Moreover, advancements in next-generation sequence technology make the tests affordable and accessible to lower-income countries further increasing the adoption rate and ultimately presenting lucrative growth opportunities for leading market players.

Personalized medicines empower patients as they recover soon, thus, patients are increasingly demanding these items for better results, which is preparing a positive market outlook for growth & expansion during the forecast period.

Global Gene Panel Market Challenge:

Lack of Skilled Workforce and Health Awareness – There is a lack of skilled workforce who have the required expertise to smoothly conduct gene panel tests. This results in high costs and ineffective treatment for the patients. Qualified professionals are required for the innovation and implementation of genetic testing solutions. This issue can be addressed by training more people professionally. Some firms are now automating these manufacturing processes. For instance,

  • To address the skills gap, US biotech company Orgenesis, which specializes in customized gene and cell treatments, is also considering automation. According to Vered Caplan, CEO of the company, one of the main obstacles in the industry is preparing staff members for aseptic processing operations in clean rooms.

Additionally, many individuals in low-income regions lack health awareness information which results in underutilization of the available gene panel tests in that region. These lacks not only affect the potential growth of the gene panel industry but also a threat to the patients suffering from the disorders. These challenges should be addressed by proper training programs, promoting health awareness programs, etc. to unlock the full benefits of Gene Panel and improve healthcare worldwide.

Global Gene Panel Market Trend:

Technological Advancements Changing Market Dynamics – Gene Panels are getting advanced day after day. Using the previous reports and treatment provided for the same, the Gene Panel market is getting precise. Gene Panels are now merged with Artificial Intelligence to diagnose and analyze the symptoms effectively. Next Generation Sequencing (NSG) technology has made gene panel tests cost-effective and time-saving along with individualized cancer treatment plans and hence becoming more accessible and affordable. Moreover, multi-gene panels are introduced which can focus on a wide range of genetic conditions simultaneously.

Moreover, biotech companies are partnering with pharmaceutical firms and academic institutions to innovate and advance gene panels. Therefore, increasing advances & innovations in gene test solutions are changing market dynamics and opening new doors for the market players to improve their revenue growth during the forecast period.

Global Gene Panel Market (2024-30): Segmentation Analysis

The Global Gene Panel Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2024–2030 at the global level. Based on the analysis, the market has been further classified as:

Based on Application:

  • Cancer Risk Assessment
  • Diagnosis of Congenital Diseases
  • Pharmacogenetics
  • Others

The cancer risk assessment segment holds the largest share of the Gene Panel Market followed by diagnosis of congenital diseases, and pharmacogenetics respectively. Gene panels are required to diagnose various diseases, cancer is a disease in which some cells of the body grow uncontrollably and then spread to other parts of the body. This is the most common disease which requires precise & continuous treatment. For instance,

  • In 2022, every day approximately 1800 women are diagnosed with cervical cancer.

By detecting genetic changes that raise the likelihood of getting specific malignancies, a gene panel can help determine a person's cancer risk. A gene panel test, often referred to as a multigene panel test, looks for abnormalities in many genes that raise the chance of developing cancer. To conduct the test, a physician may take a small sample of skin, cheek, or saliva cells. Therefore, the cancer risk assessment segment generates maximum demand for gene panels and ultimately augments the size & share of the segment in the overall industry’s growth.

Based on Design:

  • Predesigned Gene Panel
  • Customized Gene panel

The predesigned gene panel holds the largest market share but during the forecast period, the customized gene panel segment is anticipated to show a steady revenue growth due to increasing health awareness & precise treatment. The predesigned gene panel has selected and predefined genes, they are chosen as per the symptoms of the patient. They are easily accessible and can be easily affordable in lower-income countries. However, they might show wrong results sometimes when some unnecessary gene variations are observed.

On the other hand, Customized Gene Panels are defined as per the patient’s symptoms and genetic profile. It takes time to select genes for such panels and they also have high costs to the end-users. Customized gene panels focus on the genes selected only instead of all genes like the predesigned gene panels. Despite a time-consuming and expensive technique, customized gene panels are highly accurate and reliable. Moreover, this technique is a better choice for getting personalized medicines, thus projected to register steady growth in the coming years.

Global Gene Panel Market (2024-30): Regional Projections

Geographically, the Global Gene Panel Market expands across,

  • North America
  • South America
  • Europe
  • The Middle East and Africa
  • Asia-Pacific

The North American region holds the largest market share. This is due to the nations' support for genomic research. This region is providing huge investments in research for cancer and inherited rare diseases. Moreover, the presence of leading NGS providers in this region has further propelled advancements. For instance,

  • In 2022, The U.S. Centers for Disease Control and Prevention (CDC) Funds Pathogen Genomics Centre of Excellence Based in Georgia. The aim is to strengthen public health response to infectious disease threats and support public health workforce development.

Moreover, the spending on healthcare for each person is significantly increasing in this region.  For instance,

  • In 2022, U.S. healthcare spending grew 4.1 percent in 2022, reaching USD 4.5 trillion or USD 13,493 per person. This includes spending on healthcare goods, health insurance, and other investments related to healthcare.

These government initiatives and the region’s healthcare expenditure show the focus of North America on public health, hence promising the growth of the market in this region for the forecast period.

Global Gene Panel Industry Recent Developments:

  • 2024: Thermo Fisher on the Rise of Next-Generation Sequencing CDx, i.e., NGS-based in vitro diagnosing focusing on traditional Sanger sequencing and the polymerase chain reaction (PCR) methods.
  • 2023: Illumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors.

Gain a Competitive Edge with Our Global Gene Panel Market Report

  1. Global Gene Panel Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
  2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  3. Global Gene Panel Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format  - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Frequently Asked Questions

   A. The Gene Panel Market is expected to grow at a compound annual growth rate (CAGR) of around 14.2% over the forecast period.

   A. The Gene Panel Market size was valued at around USD 3.1 billion in 2023.

   A. The increasing incidences of cancer and genetic disorders are anticipated to drive the Gene Panel Market during 2024-30.

   A. The top companies in the Gene Panel Market are Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen Inc., Eurofins Scientific Se, BGI, F. Hoffmann-La Roche AG, Integrated DNA Technologies Inc., Genewiz, Inc., Novogene Corporation, Personalis, Inc., Gatc Biotech AG, Archerdx, Genedx, Centogene AG, and others.

   A. The cancer risk assessment segment held the largest share of the Gene Panel Market.

   A. The North American region would present growth prospects in the Gene Panel Market during 2024-30.

   A. Technological advancements are the key trends shaping the growth of the Gene Panel Market.

   A. The increasing demand for personalized medicines is one of the growth opportunities driving the Gene Panel Market.

   A. The lack of skilled employees and health awareness are the possible restraints affecting the growth of the Gene Market.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Gene Panel Market Regulations, Policies & Product Standards
  5. Global Gene Panel Market Trends & Developments
  6. Global Gene Panel Market Dynamics
    1. Drivers
    2. Challenges
  7. Global Gene Panel Market Hotspots & Opportunities
  8. Global Gene Panel Market Value Chain Analysis
  9. Global Gene Panel Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Service
        1. Test Kits- Market Size & Forecast 2019-2030, USD Million
        2. Testing Services- Market Size & Forecast 2019-2030, USD Million
      2. By Technique
        1. Amplicon Based Approach- Market Size & Forecast 2019-2030, USD Million
        2. Hybridization Based Approach- Market Size & Forecast 2019-2030, USD Million
      3. By Design
        1. Predesigned Gene Panel- Market Size & Forecast 2019-2030, USD Million
        2. Customized Gene Panel- Market Size & Forecast 2019-2030, USD Million
      4. By Application
        1. Cancer Risk Assessment- Market Size & Forecast 2019-2030, USD Million
        2. Diagnosis of Congenital Diseases- Market Size & Forecast 2019-2030, USD Million
        3. Pharmacogenetics- Market Size & Forecast 2019-2030, USD Million
        4. Others- Market Size & Forecast 2019-2030, USD Million
      5. By End User
        1. Academic & Research Institutes- Market Size & Forecast 2019-2030, USD Million
        2. Hospital & Diagnostic Laboratories- Market Size & Forecast 2019-2030, USD Million
        3. Pharmaceutical & Biotechnology Companies- Market Size & Forecast 2019-2030, USD Million
      6. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      7. By Company
        1. Revenue Shares
        2. Competition Characteristics
  10. North America Gene Panel Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
      2. By Technique- Market Size & Forecast 2019-2030, USD Million
      3. By Design- Market Size & Forecast 2019-2030, USD Million
      4. By Application- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. Canada Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. Mexico Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  11. South America Gene Panel Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
      2. By Technique- Market Size & Forecast 2019-2030, USD Million
      3. By Design- Market Size & Forecast 2019-2030, USD Million
      4. By Application- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    3. Brazil Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. Argentina Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  12. Europe Gene Panel Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
      2. By Technique- Market Size & Forecast 2019-2030, USD Million
      3. By Design- Market Size & Forecast 2019-2030, USD Million
      4. By Application- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. Germany
        2. The UK
        3. France
        4. Spain
        5. Italy
        6. Rest of Europe
    3. Germany Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. France Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. The UK Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    6. Spain Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    7. Italy Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  13. The Middle East & Africa Gene Panel Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
      2. By Technique- Market Size & Forecast 2019-2030, USD Million
      3. By Design- Market Size & Forecast 2019-2030, USD Million
      4. By Application- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. The UAE
        2. Saudi Arabia
        3. South Africa
        4. Rest of the Middle East & Africa
    3. The UAE Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. Saudi Arabia Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. South Africa Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  14. Asia-Pacific Gene Panel Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
      2. By Technique- Market Size & Forecast 2019-2030, USD Million
      3. By Design- Market Size & Forecast 2019-2030, USD Million
      4. By Application- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
    3. China Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. India Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. Japan Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    6. South Korea Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    7. Australia Gene Panel Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. Market Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Service- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  15. Global Gene Panel Market Key Strategic Imperatives for Growth & Success
  16. Competitive Outlook
    1. Company Profiles
      1. Illumina, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Thermo Fisher Scientific Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Agilent Technologies
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Qiagen Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Eurofins Scientific Se
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. BGI
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. F. Hoffmann-La Roche AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Integrated DNA Technologies Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Genewiz, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Novogene Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Personalis, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Gatc Biotech AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Archerdx
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Genedx
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Centogene AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  17. Disclaimer


Gene Panel Market Segmentation Slide